Cigma & Humana Merger
Cigna and Humana are two of the largest health insurance companies in the United States. In December 2022, they announced plans to merge, creating a company with over 150 million members and $200 billion in annual revenue. The merger is expected to close in 2023, pending regulatory approval.
Benefits of the Merger
Proponents of the merger argue that it will create a more efficient and powerful company that can better serve its customers. They say that the combined company will have the scale and resources to invest in new technologies and products, and to improve customer service. They also argue that the merger will lead to lower costs for consumers.
Concerns about the Merger
Critics of the merger argue that it will lead to higher prices for consumers, as the combined company will have more market power. They also argue that the merger will reduce competition in the health insurance market, which could lead to less innovation and fewer choices for consumers.
The merger is currently under review by the U.S. Department of Justice and the Federal Trade Commission. These agencies are responsible for ensuring that mergers do not harm competition. It is unclear whether the agencies will approve the merger.
Impact on the Health Insurance Market
If the merger is approved, it will have a significant impact on the health insurance market. The combined company would be the largest health insurer in the United States, with a market share of over 20%. This could lead to higher prices for consumers and less competition.
The proposed merger between Cigna and Humana is a complex issue with both potential benefits and drawbacks. It is important to carefully consider all of the potential impacts of the merger before making a decision.